Loss of Expression of the p16 Tumor Suppressor Gene Is More Frequent in Advanced Ovarian Cancers Lacking p53 Mutations

Author： Havrilesky L.J.   Alvarez A.A.   Whitaker R.S.   Marks J.R.   Berchuck A.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.83, Iss.3, 2001-12, pp. : 491-500

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spectrum of p53 Tumor Suppressor Gene Mutations and Breast Cancer Survival

By Lai Hong  

Breast Cancer Research and Treatment, Vol. 83, Iss. 1, 2004-01 ,pp. : 57-66

Springer Publishing Company

Access to resources Recommend Favorite

Poor Correlation with Loss of Heterozygosity on Chromosome 17p and p53 Mutations in Ovarian Cancers

By Sakamoto T.   Nomura N.   Mori H.   Wake N.  

Gynecologic Oncology, Vol. 63, Iss. 2, 1996-11 ,pp. : 173-179

Academic Press

Access to resources Recommend Favorite

Transcriptional regulation of the p53 tumor suppressor gene

By Reisman D.   Loging W.T.  

Seminars in Cancer Biology, Vol. 8, Iss. 5, 1997-10 ,pp. : 317-324

Academic Press

Access to resources Recommend Favorite

Expression of the p53 tumour suppressor gene as a prognostic marker in platinum-treated patients with ovarian cancer

By Marx D.   Meden H.   Ziemek T.   Lenthe T.   Kuhn W.   Schauer A.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 845-850

Elsevier

Access to resources Recommend Favorite

Mutations of the p53 Gene and Loss of Heterozygosity at Chromosome 17p13.1 are Associated with Increased Survivin Expression in Breast Cancer

By Tsuji Naoki  

Breast Cancer Research and Treatment, Vol. 87, Iss. 1, 2004-09 ,pp. : 23-31

Springer Publishing Company

Access to resources Recommend Favorite